Management of Intoxication
In addition to general and supportive measures, all patients were treated with gastric lavage and activated charcoal (100 g once) via nasogastric tube. The patients also received intravenous infusion of atropine to counteract bronchial hypersecretion and bradycardia. Oximes were not administered, although they had been given to nine patients prior to ICU admission.
Data Collection and Analysis
Serum cholinesterase activity was measured by spectrophotometry in all patients at the time of ICU admission. The normal value for serum cholinesterase activity in our laboratory ranged from 3,500 to 8,500 U/L.
Severity of intoxication was then assessed according to each of the following processes. First, severity was evaluated by a grading system previously validated by Bardin and Van eeden.8 This grading is based on specific clinical findings pertaining mainly to the respiratory and central nervous systems and on the results of procedures such as chest radiographs and blood gas values. The revised form of this grading system categorized poisoning into three groups: mild, severe, and life-threatening poisoning. For the purpose of the current study, we combined mild and severe poisoning grades (mild-severe poisoning patients: group 1, n=18). The remaining patients formed the second group (life-threatening poisoning patients: group 2, n=12). Second, severity of intoxication was also assessed by the simplified acute physiology score (SAPS),'1 the amount of atropine required to maintain its full effects (mydriasis, tachycardia, flushing, xerostomia, anhydrosis), and by the need for mechanical ventilation.
Comparison of cholinesterase level was performed between group 1 and group 2 patients and between mechanically ventilated and nonmechanically ventilated patients. Correlations were sought between serum cholinesterase activity and the other selected parameters of severity, namely SAPS found between serum cholinesterase level and the total atropine requirement. Of interest, mean SAPS was significantly higher in group 2 than in group 1 patients (12.2 ± 5 vs 3.5 ± 3.4, respectively, p<0.001). However, no correlation was found between SAPS and serum cholinesterase activity.
DISCUSSION
The current study showed that in acute OPP, serum cholinesterase level measured at the time of ICU admission does not correlate with the clinical severity of poisoning. These findings could hardly be ascribed to the variable time between organophosphate exposure and the blood sampling for cholinesterase measurement. In most of our patients, this interval was less than 24 h, a period of time during which inhibition of serum cholinesterase activity reaches its maximum. 3, 4 It is believed that the toxicologic effects of OP are primarily, if not entirely, due to inhibition of acetylcholinesterase and to the subsequent accumulation of acetylcholine at the cholinergic synapses. Serum level of this enzyme is taken into account in the original grading of severity of OPP proposed by Namba and coworkers.4 Indeed these authors categorized patients into four groups, with latent, mild, moderate, and serious poisoning, on the basis of clinical findings and the serum cholinesterase level. However, to our knowledge, this classification has never been validated. Moreover, most of the studies suggesting the relationship between serum cholinesterase level and severity of acute OPP were based on some case reports.12-15 The largest study dealing with the prognostic significance of cholinesterase level was conducted in 107 patients by Tsao et a16 who found that respiratory failure developed almost exclusively in patients classified as having moderately severe or severe poisoning on the basis of the decrease of serum cholinesterase activity. They also found that survival was significantly higher in patients who exhibited a very mild decrease of this enzyme. However, the results of this study were seriously hampered by the heterogeneous enrollment criteria, since 13 patients had acute carbamate poisoning and 14 had either an association of carbamate and OP poisoning or an uncertain agent. Since some carbamate compounds may act as cholinesterase inhibitors, they may represent a confounding factor in the interpretation of the clinical course in this group of patients.16
Correlation between serum cholinesterase level and death rate is probably more interesting than any other severity grading. However, only three deaths occurred in our study making it impossible to use this criterion. Therefore, we elected to correlate serum cholinesterase level with indices of severity that do not include serum cholinesterase activity such as the scale of Bardin et al5'8 and SAPS. The scale of Bardin et al5'8 is a specific grading system previously validated in patient victims of OPP. However, SAPS is a reliable general index used for a large range of patients in the ICU." This scoring system showed that the degree of physiologic derangement correlates closely with the outcome in overall critically ill patients and even for relatively small groups of patients within specific disease categories such as acute pancreatitis and cardiogenic shock. '7"8 In the present study, we showed the reliability of this score to stratify patients with acute OPP prognostically since we found a significantly higher SAPS in group 2 than in group 1 patients according to the severity grading system of Bardin et al. 5'8 To the best of our knowledge, this is the first study that validates SAPS"1 as an indicator of severity in acute OPP.
The amount of atropine required to maintain its full effects is often used to reflect the severity of oPP.2'6 In our study, atropine requirement did not correlate with serum cholinesterase level. One explanation to these findings is that atropine is only a muscarinic receptor antagonist whereas cholinergic crisis symptoms are relevant to overstimulation at variable degree of both muscarinic and nicotinic receptors.1 Consequently, atropine was required only when muscarinic symptoms were present. Indeed, seven of our patients (four patients in group 1 and three in group 2) did not receive atropine. In these patients, the diagnosis of OPP was based on a positive history of intake or exposure and low serum cholinesterase level.
The need for assisted ventilation is usually considered as an indicator of illness severity in patients with acute opp.6 However, we were unable to find any statistically significant difference in mean serum cholinesterase levels between mechanically ventilated patients and patients who did not require mechanical ventilation.
Although numerous experimental studies have reported the lack of relationship between cholinesterase activity and clinical severity,'1920 clinical data supporting these findings are limited.5'2' Our study confirmed that serum cholinesterase level is not reliable to assess the clinical severity of acute OPP. Some explanations for these findings could be proposed. First, tissue concentration of cholinesterase (true cholinesterase), which is thought to be more closely related to clinical manifestations of poisoning, is poorly correlated with plasma level of the enzyme (pseudocholinesterase).5 The respective sensitivity of these two enzyme species to OP inhibition is probably different. Second, it seems possible that a direct OP toxic reaction independent of cholinergic mediation may occur; this hypothesis was previously postulated to explain some aspects of the cardiac disorders seen in CHEST / 106/ 6 / DECEMBER, 1994 1813 patients with acute opp.22
In summary, no correlation between serum cholinesterase level and the severity of OPP was found in this study. A grading system to identify high-risk cases in OPP based on the plasma level of this enzyme is therefore not reliable. Cholinesterase level should be considered no more than a marker of OP intoxication and does not involve any prognostic implication.
